[18F]FDG imaging of head and neck tumours: Comparison of hybrid PET and morphological methods

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 7, 2003, Pages 995-1003

  Dresel, S ^a   Grammerstorff, J ^a   Schwenzer, K ^a   Brinkbaumer K ^a   Schmid, R ^a   Pfluger, T ^a   Hahn, K ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

18F FDG; Coincidence imaging; Head and neck tumours; Hybrid PET

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; FOLLOW UP; HEAD AND NECK TUMOR; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; CARCINOMA; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEASIBILITY STUDY; INSTRUMENTATION; MELANOMA; METASTASIS; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; FEASIBILITY STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0042693241     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1181-6     Document Type: Article

References (32)

1. Laubenbacher C, Saumweber D, Wagner-Manslau C, Kau R J, Herz M, Avril N, Ziegler S, Kruschke C, Arnold W, Schwaiger M. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 1995; 36:1747-1757.
2. Nowak B, Di Martino E, Jänicke S, Cremerius U, Adam G, Zimny M, Reinartz P, Büll U. Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI. Nuklearmedizin 1999; 38:312-318.
3. Shah JP. Cervical lymph node metastases - diagnostic, therapeutic and prognostic implications. Oncology 1990; 4:61-69.
4. Ali S, Tiwar RM, Snow GB. False positive and false-negative neck nodes. Head Neck Surg 1985; 8:78-82.
5. Hillsamer PJ, Schuller DE, McGhee RB, Chakeres D, Young DC. Improving diagnostic accuracy of cervical metastases with computed tomography and magnetic resonance imaging. Arch Otolaryngol Head Neck Surg 1990; 116:1297-1301.
6. van den Brekel MWM, Stel HV, Castelijns JA, Nauta JJ, van der Waal I, Valk J, Meyer CJ, Snow GB. Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 1990; 177:379-384.
7. Dillon WP, Harnsberger HR. The impact of radiologic imaging on staging of cancer of the head and neck. Semin Oncol 1991; 18:64-79.
8. Quetz JU, Rohr S, Hoffmann P, Wustrow J, Mertens J. B-image sonography in lymph node staging of the head and neck area. A comparison with palpation, computerized and magnetic resonance tomography. HNO 1991; 39:61-63.
9. van den Brekel MWM, Catelijns JA, Croll GA, Stel HV, Valk J, van der Waal I, Golding RP, Meyer CJ, Snow GB. Magnetic resonance imaging versus palpation of cervical lymph node metastases. Arch Otolaryngol Head Neck Surg 1991; 117:666-673.
10. Heppt W, Haels J, Lenarz T, Mende U, Gademann G. Detection and assessment of cervical lymph node metastases in head-neck tumors. A comparison of methods. Laryngorhinootologie 1989; 68:327-332.
11. Minn H, Joensuu H, Ahonen A, Klemi P. Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Cancer 1988; 61:1776-1781.
12. Minn H, Clavo A C, Grenman R, Wahl R L. In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose andL-methionine in squamous-cell carcinoma of the head and neck. J Nucl Med 1995; 36:252-258.
13. Haberkorn U, Strauss L G, Reisser C, Haag D, Dimitrakopoulou A, Ziegler S, Oberdorfer F, Rudat V, van Kaick G. Glucose uptake, perfusion and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry. J Nucl Med 1991; 32:1548-1555.
14. Jarritt PH, Acton PD. PET imaging using gamma camera systems: a review. Nucl Med Commun 1996; 17:758-766.
15. Zimny M, Kaiser H-J, Cremerius U, Sabri O, Schreckenberger M, Reinartz P, Büll U. F-18-FDG-Positronen-Emissions-Tomographie bei onkologischen Patienten: Doppelkopf-Koinzidenz-Gammakamera versus Vollring-PET. Nuklearmedizin 1999; 38:108-114.
16. Pichler R, Maschek W, Hatzl-Griesenhofer M, Huber H, Wimmer G, Wahl G, Fridrik M. Klinische Wertigkeit der Befunde von FDG-PET mittels Koinzidenz-Gammakamera beim Staging and Restaging maligner Lymphome: ein Vergleich zu konventioneller Diagnostik. Nuklearmedizin 2000; 39:166-173.
17. Harnsberger H, Mancuso A, Muraki A, Parkin J. The upper aerodigestive tract and neck: CT evaluation of recurrent tumors. Radiology 1983; 149:403-409.
18. Bronstein AD, Nyberg DA, Schwartz AN, Schumann WP, Griffin BR. Soft tissue changes after head and neck radiation: CT findings. Am J Neurol Rad 1989; 10:171-175.
19. Jabour BA, Choi Y, Hoh CK, Rege SD, Soong JC, Lufkin RB, Hanafee WN, Maddahi J, Chaiken L, Bailet J. Extracranial head and neck: PET imaging with 2-[F-18] fluoro-2-deoxy-D-glucose and MR imaging correlation. Radiology 1993; 186:27-35.
20. Anzai Y, Carroll WR, Quint DJ, Bradford CR, Minoshima S, Wolf GT, Wahl RL. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2[F-18]-fluoro-D-glucose PET and MR imaging diagnosis. Radiology 1996; 200:135-141.
21. Bailet JW, Abemayor E, Jabour BA, Hawkins RA, Hoh C, Ward PH. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumours and assessment of cervical adenopathy. Laryngoscope 1992; 102:281-288.
22. Braams JW, Pruim J, Kole AC, Nikkels PG, Vaalburg W, Vermey A, Roodenburg JL. Detection of unknown primary head and neck tumours by positron emissions tomography. Int J Oral Maxillofac Surg 1997; 26:112-115.
23. Engel H, Steinert H, Buck A, Berthold T, Boni AH, von Schulthess GK. Whole-body PET: physiological and artifactual fluordeoxyglucose accumulations. J Nucl Med 1996; 37:441-446.
24. Lapela M, Grenman R, Kurki T, Joensuu H, Leskinen S, Lindholm P, Haaparanta M, Ruotsalainen U, Minn H. Head and neck cancer: detection of recurrence with PET and 2-[F18]fluoro-2-deoxy-D-glucose. Radiology 1995; 197:205-211.
25. Stokkel MPM, Terhaard CHJ, Hordijk GJ, van Rijk PP. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography. Eur J Nucl Med 1999; 26:767-773.
26. Braams JW, Pruim J, Freling NJM, Nikkels PG, Roodenburg JL, Boering G, Vaalburg W, Vermey A. Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 1995; 36:211-216.
27. Mc Guirt WF, Williams DW, Keyes JW, Greven KM, Watson NE, Geisinger KR, Cappellari JO. A comparative diagnostic study of head and neck nodal metastases using positron emission tomography. Laryngoscope 1995; 105:373-375.
28. Abdel-Nabi H, Spaulding MB, Behar P, Nguyen A, Simpson G, Gona J. Value of PET-FDG imaging in the pre-operative work-up of patients with head and neck carcinomas. J Nucl Med 1996; 37:136P.
29. Stokkel MPM, ten Broek FW, van Rijk PP. Preoperative assessment of cervical lymph nodes in head and neck cancer with fluorine-18 fluorodeoxyglucose using a dual-head coincidence camera: a pilot study. Eur J Nucl Med 1999; 26:499-503.
30. 18F-FDG using a dual head coincidence camera [abstract]. Eur J Nucl Med 1998; 25:1032.
31. Jungehülsing M, Scheidhauer K, Damm M, Pietrzyk U, Eckel H, Schicha H, Stennert E. 2[F]-fluoro-2-deoxy-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation. Otolaryngol Head Neck Surg 2000; 123:294-301.
32. Pfluger T, Vollmar C, Wismuller A, Dresel S, Berger F, Suntheim P, Leinsinger G, Hahn K. Quantitative comparison of automatic and interactive methods for MRI-SPECT image registration of the brain based on 3-dimensional calculation of error. J Nucl Med 2000; 41:1823-1829.